Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUE-AHF phase III trial of ularitide in acute decompensated heart failure
NL-OMON41438Phase 3Active, not recruiting
- Sponsor
- Cardiorentis AG
- Start
- May 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Ularitide with Placebo (2 arms). Started May 2013; status: active, not recruiting.
02
Drugs
ularitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON41438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41438.